Krka
Phone: +386 7 331 21 11
Fax: (+386) 7 332 15 37
E-mail: info@krka.biz
Type | Public |
---|---|
Industry | Pharmaceutical |
Founded | 23 April 1954 (1954-04-23) |
Headquarters | Šmarješka cesta 6, Novo Mesto, Slovenia |
Key people | Jože Colarič (CEO) |
Products | Prescription pharmaceuticals, non-prescription products, animal health products, health-resort and tourist services |
Revenue | €1.332 billion (2018) |
Number of employees | 11,390 (2018) |
Website | www.krka.biz/en |
Krka is one of the largest generic pharmaceutical companies in the world, with more than 60 years of experience of manufacturing high quality generic pharmaceutical products. We have been successfully implementing our strategies, and pursuing our goals and visions for over half a century. Krka is one of the world’s leading generic pharmaceutical companies. Our medicines are used to treat more than 50 million patients every day in over 70 markets.
For detailed contact information visit location pages below.
Krka's locations around the world
Clinical Trials sponsored by Krka
-
University Medical Centre LjubljanaKRKAValmis
-
KRKAUniversity Medical Centre Maribor; 3ARH; INTERBORALopetettuKivulias diabeettinen perifeerinen neuropatiaSerbia, Kroatia, Pohjois-Makedonia, Puola, Slovenia
-
Slovenian Society for Gastroenterology and HepatologyKRKAEi vielä rekrytointiaHelicobacter pylori -infektio | HävityshoidotSlovenia
-
Russian Cardiology Research and Production CenterKRKAValmisHypertensiivinen kiireellisyysVenäjän federaatio
-
KRKAUniversity Medical Centre Ljubljana; University of Ljubljana School of Medicine... ja muut yhteistyökumppanitValmisÄäreisvaltimotautiSlovenia
-
KRKAUniversity Medical Centre Ljubljana; Clinres Farmacija d.o.o.ValmisHypertensioArmenia, Kroatia, Unkari, Puola, Venäjän federaatio, Serbia, Slovenia
-
University of PecsHungarian Academy of Sciences; KRKAValmisSepelvaltimotauti | Perkutaaninen sepelvaltimointerventio